数字健康技术证据与获取的国家政策核心要素。
Core elements of national policy for digital health technology evidence and access.
作者信息
Coder Megan, McBride Lacey, McClenahan Samantha
机构信息
Digital Medicine Society (DiMe), Boston, MA, USA.
出版信息
NPJ Digit Med. 2024 Aug 13;7(1):212. doi: 10.1038/s41746-024-01209-2.
Abstract
Digital health technologies (DHT) offer the ability to deliver personalized care, lower barriers to access, and positively impact health outcomes. However, DHT utilization is impacted by insufficient market access pathways. A policy “full-stack”—including regulatory authorization, product value assessment, pricing and reimbursement, and patient access infrastructure—offers a framework for DHT integration into national healthcare ecosystems. Consistent clinical evidence requirements across national jurisdictions will further increase DHT scalability.
摘要
数字健康技术（DHT）能够提供个性化护理，降低获取医疗服务的障碍，并对健康结果产生积极影响。然而，DHT的应用受到市场准入途径不足的影响。一项包括监管授权、产品价值评估、定价与报销以及患者获取基础设施的政策“全栈式方案”，为DHT融入国家医疗生态系统提供了一个框架。各国司法管辖区统一的临床证据要求将进一步提高DHT的可扩展性。
相似文献
1
Core elements of national policy for digital health technology evidence and access.数字健康技术证据与获取的国家政策核心要素。
NPJ Digit Med. 2024 Aug 13;7(1):212. doi: 10.1038/s41746-024-01209-2.
2
Mapping national information and communication technology (ICT) infrastructure to the requirements of potential digital health interventions in low- and middle-income countries.将国家信息和通信技术（ICT）基础设施映射到中低收入国家潜在数字健康干预措施的要求。
J Glob Health. 2022 Dec 29;12:04094. doi: 10.7189/jogh.12.04094.
3
Post-Pandemic Telehealth Policy for Primary Care: An Equity Perspective.大流行后初级保健的远程医疗政策：公平视角。
J Am Board Fam Med. 2022 May-Jun;35(3):588-592. doi: 10.3122/jabfm.2022.03.210509.
4
Nurses as Stakeholders in the Adoption of Mobile Technology in Australian Health Care Environments: Interview Study.澳大利亚医疗保健环境中护士作为移动技术采用利益相关者的访谈研究
JMIR Nurs. 2019 Aug 9;2(1):e14279. doi: 10.2196/14279. eCollection 2019 Jan-Dec.
6
EVALUATION OF THE HTA CORE MODEL FOR NATIONAL HEALTH TECHNOLOGY ASSESSMENT REPORTS: COMPARATIVE STUDY AND EXPERIENCES FROM EUROPEAN COUNTRIES.国家卫生技术评估报告的 HTA 核心模型评价：来自欧洲国家的比较研究和经验。
Int J Technol Assess Health Care. 2017 Jan;33(6):644-653. doi: 10.1017/S026646231700099X. Epub 2017 Nov 21.
7
Tanzania's and Germany's Digital Health Strategies and Their Consistency With the World Health Organization's Global Strategy on Digital Health 2020-2025: Comparative Policy Analysis.坦桑尼亚和德国的数字健康战略及其与世界卫生组织 2020-2025 年全球数字健康战略的一致性：比较政策分析。
J Med Internet Res. 2024 Mar 18;26:e52150. doi: 10.2196/52150.
8
Digital technology and national entrepreneurship: An ecosystem perspective.数字技术与国家创业精神：生态系统视角
J Technol Transf. 2023;48(3):1077-1105. doi: 10.1007/s10961-022-09934-0. Epub 2022 May 17.
9
Digital Technology Access and Health-Related Internet Use Among People Experiencing Homelessness in Hungary: Quantitative Survey.匈牙利流浪人群的数字技术获取和与健康相关的互联网使用情况：定量调查。
J Med Internet Res. 2022 Oct 19;24(10):e38729. doi: 10.2196/38729.
10
Impact of Digital Inclusion Initiative to Facilitate Access to Mental Health Services: Service User Interview Study.数字包容倡议对促进心理健康服务获取的影响：服务使用者访谈研究。
JMIR Ment Health. 2024 Jul 26;11:e51315. doi: 10.2196/51315.
引用本文的文献
1
Comprehensive policies for scaling systemic and equitable integration of digital health technologies.扩大数字健康技术系统性和公平整合的综合政策。
NPJ Digit Med. 2025 Jul 4;8(1):404. doi: 10.1038/s41746-025-01820-x.
2
Digital Therapeutics for Cognitive Impairment: Exploring Innovations, Challenges, and Future Prospects.用于认知障碍的数字疗法：探索创新、挑战与未来前景
J Med Internet Res. 2025 Jun 12;27:e73689. doi: 10.2196/73689.
3
The need to update Ethiopia's national health and medicine policies: essential tools for informed decision-making in healthcare and the pharmaceutical sectors.更新埃塞俄比亚国家卫生与医学政策的必要性：医疗保健和制药部门明智决策的重要工具。
Front Public Health. 2025 Apr 25;13:1533710. doi: 10.3389/fpubh.2025.1533710. eCollection 2025.
4
Perceived acceptance, intention to use and actual use behavior of digital information technologies among nursing professionals in Shanghai: a cross-sectional study.上海护理专业人员对数字信息技术的感知接受度、使用意愿及实际使用行为：一项横断面研究
BMC Nurs. 2025 Apr 16;24(1):431. doi: 10.1186/s12912-025-03078-w.
5
Unpacking Performance Factors of Innovation Systems and Studying Germany's Attempt to Foster the Role of the Patient Through a Market Access Pathway for Digital Health Applications (DiGAs): Exploratory Mixed Methods Study.剖析创新系统的绩效因素并研究德国通过数字健康应用（DiGAs）的市场准入途径促进患者作用的尝试：探索性混合方法研究。
J Med Internet Res. 2025 Jan 6;27:e66356. doi: 10.2196/66356.
6
"Towards harmonizing assessment and reimbursement of digital medical devices in the EU through mutual learning".通过相互学习促进欧盟数字医疗设备评估与报销的协调统一
NPJ Digit Med. 2024 Oct 1;7(1):268. doi: 10.1038/s41746-024-01263-w.
7
Mapping the regulatory landscape for artificial intelligence in health within the European Union.绘制欧盟范围内人工智能在医疗领域的监管格局。
NPJ Digit Med. 2024 Aug 27;7(1):229. doi: 10.1038/s41746-024-01221-6.
本文引用的文献
1
Assessing the Value of Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Toward a Value Framework Based on Multistakeholder Perceptions.评估用于慢性病管理的面向提供者的数字健康技术的价值：基于多利益相关者感知的价值框架。
Med Decis Making. 2024 Jan;44(1):28-41. doi: 10.1177/0272989X231206803. Epub 2023 Oct 26.
2
Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping.8 个欧洲国家和以色列的数字健康报销策略：范围综述和政策映射。
JMIR Mhealth Uhealth. 2023 Sep 29;11:e49003. doi: 10.2196/49003.
3
International practices in health technology assessment and public financing of digital health technologies: recommendations for Hungary.国际卫生技术评估和数字健康技术公共筹资实践：对匈牙利的建议。
Front Public Health. 2023 Aug 31;11:1197949. doi: 10.3389/fpubh.2023.1197949. eCollection 2023.
4
Mapping Factors That Affect the Uptake of Digital Therapeutics Within Health Systems: Scoping Review.映射影响数字疗法在医疗体系内采用的因素：范围综述。
J Med Internet Res. 2023 Jul 25;25:e48000. doi: 10.2196/48000.
5
A Value Framework to Assess Patient-Facing Digital Health Technologies That Aim to Improve Chronic Disease Management: A Delphi Approach.评估旨在改善慢性病管理的面向患者的数字健康技术的价值框架：德尔菲法。
Value Health. 2023 Oct;26(10):1474-1484. doi: 10.1016/j.jval.2023.06.008. Epub 2023 Jun 28.
6
Digital health, digital medicine, and digital therapeutics in cardiology: current evidence and future perspective in Japan.心脏病学中的数字健康、数字医学和数字疗法：日本的当前证据和未来展望。
Hypertens Res. 2023 Sep;46(9):2126-2134. doi: 10.1038/s41440-023-01317-8. Epub 2023 May 31.
7
The hard way from the Beveridge to the Bismarck model of health finance: Expectations and reality in Russia.从贝弗里奇模式到俾斯麦模式的艰难转变：俄罗斯的期望与现实。
Front Public Health. 2023 Mar 14;11:1104209. doi: 10.3389/fpubh.2023.1104209. eCollection 2023.
8
One year of digital health applications (DiGA) in Germany - Rheumatologists' perspectives.德国数字健康应用程序（DiGA）的一年——风湿病学家的观点。
Front Med (Lausanne). 2022 Oct 25;9:1000668. doi: 10.3389/fmed.2022.1000668. eCollection 2022.
9
Reimbursement of Digital Therapeutics: Future Perspectives in Korea.数字疗法的报销：韩国的未来展望
Korean Circ J. 2022 Apr;52(4):265-279. doi: 10.4070/kcj.2022.0014.
10
Health app policy: international comparison of nine countries' approaches.健康应用政策：九个国家方法的国际比较
NPJ Digit Med. 2022 Mar 18;5(1):31. doi: 10.1038/s41746-022-00573-1.
Zotero 插件